4D Molecular Therapeutics Inc (FDMT)
Healthcare
Biotechnology
—
10.20 $
+1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
4D Molecular Therapeutics Inc (FDMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -68 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22 | -1.2 | -25 | -29 | -30 | -29 | -46 | -48 | -43 | -46 | 29 | -68 | -129 | |
| 1.4 | 1.4 | 1.5 | 1.6 | 1.6 | 1.7 | 1.8 | 1.8 | 1.9 | 2.0 | 2.0 | 2.1 | 7.9 | |
| 5.0 | 4.6 | 5.9 | 6.0 | 6.1 | 6.5 | 7.6 | 7.0 | 5.0 | 4.5 | 5.6 | 4.5 | 19 | |
| 5.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.4 | 3.1 | 0.7 | -3.5 | -0.7 | 8.5 | -3.7 | -7.2 | 5.6 | 5.0 | 2.8 | -4.8 | 8.6 | |
| 0.8 | 0.4 | 0.5 | 0.7 | 0.3 | 1.8 | 0.9 | 0.6 | 0.1 | 0.1 | 0.6 | 0.0 | 0.8 | |
| 49 | 30 | -6.7 | -263 | -74 | 27 | 7.1 | 32 | -14 | 18 | -129 | 69 | -56 | |
| 128 | – | – | – | – | – | – | – | – | – | 7.5 | – | – | |
| 131 | 11 | 4.8 | 319 | 17 | 0.6 | 0.6 | 0.0 | 0.9 | 0.1 | 112 | 11 | 124 | |
| 158 | 39 | -27 | 26 | -87 | -1.5 | -38 | -16 | -64 | -29 | 12 | 12 | -68 | |
| -23 | -1.6 | -25 | -30 | -31 | -31 | -47 | -48 | -43 | -46 | 28 | -68 | -130 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.